Jennifer Jenks

Jennifer JenksMSTP/MGM Graduate Student (2017)
Permar Lab
DHVI / 2 Genome Court, MSRB II
DUMC 103020
Durham, NC 27713
Phone: 919-684-5384
Fax: 919-681-8992
Email: jennifer.jenks@duke.edu

INTERESTS:

Research Interest: Immunology, vaccine development, herpesviruses, T cell biology

Personal Interests: Running, traveling, hiking, meeting new people, playing the piano, volunteering

Publications List:

  1. Nelson CS, et al. HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions. PNAS. 2018 Jun 12;115(24):6267-6272.
  2. Pellerin L, Jenks JA, et al. Peanut-specific Tr1 cells induced in vitro from allergic individuals are functionally impaired. 2018 Jan;141(1):202-213.e8.
  3. Hoh RA, et al. Single B-cell deconvolution of peanut-specific antibody responses in allergic patients. 2016 Jan;137(1):157-167.
  4. Jenks JA, Nadeau KC. (2015) Ch. 126: Severe Combined Immunodeficiency (SCID). In Neonatology: Text and Atlas. McGraw Hill: New York, NY.
  5. Spencer AJ, et al. Enhanced vaccine-induced CD8+ T cell responses to malaria antigen ME-TRAP by fusion to MHC class II invariant chain. PLoS One. 2014 Jun 19;9(6):e100538.
  6. Pellerin L, Jenks JA. Regulatory T cells and their roles in Immune dysregulation and Allergy. Immunol Rev. 2014 May;58(2-3):358-68.
  7. Kanai T, et al. Identification of STAT5A and STAT5B target genes in human T cells. PLoS One. 2014 Jan 30;9(1):e86790.
  8. Jenks JA, et al. Differentiating the roles of STAT5B and STAT5A in human CD4+ T cells. Clin Immunol. 2013 Aug;148(2):227-36.
  9. Kanai T, Jenks JA, Nadeau KC. The STAT5b Pathway Defect and Autoimmunity. Front Immunol. 2012 Aug 14;3:234. (shared first authorship)